Results 71 to 80 of about 10,636 (185)

Neuroleptic malignant syndrome in a patient with moderate intellectual disability treated with olanzapine: A case report

Clinical Case Reports, 2021
This case demonstrates the challenges encountered in a case of Neuroleptic Malignant Syndrome in a young woman with moderate Intellectual Disability.
Francesco Piacenza, Suet Kee Ong, Patrick O’Brien, Maurice Clancy   +3 more
doaj   +1 more source

Haloperidol and Ziprasidone for Treatment of Delirium in Critical Illness [PDF]

, 2018
BACKGROUND: There are conflicting data on the effects of antipsychotic medications on delirium in patients in the intensive care unit (ICU). METHODS: In a randomized, double-blind, placebo-controlled trial, we assigned patients with acute ...
Bernard, G.R., Boehm, L.M., Bowton, D.L., Brummel, N.E., Carson, S.S., Chandrasekhar, R., Dittus, R.S., Douglas, I.S., Ely, E.W., Exline, M.C., Feinstein, D.J., Girard, T.D., Gong, M.N., Hite, R.D., Hough, C.L., Hughes, C.G., Hyzy, R.C., Jackson, J.C., Khan, B., Malhotra, A., Masica, A.L., Owens, R.L., Pandharipande, P.P., Patel, M.B., Pisani, M.A., Pun, B.T., Rock, P., Schmidt, G.A., Schweickert, W.D., Stollings, J.L., Strength, C., Thompson, J.L.   +31 more
core   +1 more source

Six‐Year Trends in Real‐World Data Use for Post‐Marketing Surveillance of New Medical Products in Japan

Clinical and Translational Science, Volume 19, Issue 2, February 2026.
ABSTRACT The Ministerial Ordinance on Good Post‐Marketing Study Practice for Drugs was amended by the Ministry of Health, Labour and Welfare (MHLW) in 2018 to clearly define post‐marketing database studies (DBS) as a measure of pharmacovigilance activities for approved medical products in Japan.
Suguru Okami, Kako Shimotsumagari, Yasunari Sadatsuki   +2 more
wiley   +1 more source

Overlapping of Serotonin Syndrome with Neuroleptic Malignant Syndrome due to Linezolid-Fluoxetine and Olanzapine-Metoclopramide Interactions: A Case Report of Two Serious Adverse Drug Effects Caused by Medication Reconciliation Failure on Hospital Admission

Case Reports in Medicine, 2016
Antipsychotic and antidepressant are often used in combination for the treatment of neuropsychiatric disorders. The concomitant use of antipsychotic and/or antidepressant with drugs that may interact can lead to rare, life-threatening conditions such as ...
Faizan Mazhar, Shahzad Akram, Nafis Haider, Rafeeque Ahmed   +3 more
doaj   +1 more source

Neuroleptic malignant syndrome due to risperidone misdiagnosed as status epilepticus

Pediatric Reports, 2011
Neuroleptic malignant syndrome (NMS) is a rare but potentially fatal disease characterized by fever, muscle rigidity, delirium and autonomic instability. Here we report a child, with NMS due to the risperidone misdiagnosed as status epilepticus.
Ali Ertug Arslankoylu, Meryem Ozlem Kutuk, Cetin Okuyaz, Fevziye Toros   +3 more
doaj   +1 more source

TREC-Rio trial: a randomised controlled trial for rapid tranquillisation for agitated patients in emergency psychiatric rooms [ISRCTN44153243] [PDF]

, 2002
Agitated or violent patients constitute 10% of all emergency psychiatric treatment. Management guidelines, the preferred treatment of clinicians and clinical practice all differ.
A Jablensky, B Thornley, CB Joy, Clive E Adams, E Coutinho, Evandro SF Coutinho, Expert Consensus Guideline Group, F Moritz, G Huf, Gisele Huf, HI Kaplan, J Ludbrook, JG Cunnane, LS Pilowsky, M Fenton, M Hotopf, M Wyant, P Armitage, RL Binder, The Royal College of Psychiatrists, VW Berger, Z Atakan   +21 more
core   +3 more sources

Comorbidities in People With Intellectual Disability With and Without Schizophrenia and Schizophrenia Without Intellectual Disability: A Swedish Register Study (IDcare)

Journal of Intellectual Disability Research, Volume 70, Issue 2, Page 206-217, February 2026.
ABSTRACT Background Intellectual disability (ID) and schizophrenia are known to separately carry a high risk of comorbidity of mental health and physical conditions. However, the prevalence and risk of comorbidities among people diagnosed with concurrent ID and schizophrenia have to date not been studied.
Trine Lise Bakken, Anna Axmon, Magnus Sandberg   +2 more
wiley   +1 more source

Neuroleptic Malignant Syndrome - Diagnostic Challenges in the Emergency Room [PDF]

, 2008
Introdução - Síndroma maligna dos neurolépticos (SMN) é um efeito secundário raro potencialmente fatal destes fármacos. Relato de caso - Sexo masculino, 18 anos, encefalopatia não progressiva, atraso global do desenvolvimento, epilepsia, perturbação do
Calado, E, Pimentel, S, Silva, R
core  

Catatonia and elevated mortality: A population‐wide cohort study with healthy, sibling, and schizophrenia spectrum controls

Psychiatry and Clinical Neurosciences, Volume 80, Issue 2, Page 121-128, February 2026.
Aim To determine whether catatonia is associated with increased long‐term all‐cause and cause‐specific mortality. Methods Using Taiwan's National Health Insurance Database (2000–2022), we assembled a population‐based cohort of all adults (≥18 years) with catatonia and matched each to four controls without catatonia on sex and birthdate.
Chih‐Wei Hsu, Yang‐Chieh Brian Chen, Marco Solmi, Chih‐Sung Liang, Mu‐Hong Chen, Yao‐Hsu Yang, Liang‐Jen Wang, Edward Chia‐Cheng Lai   +7 more
wiley   +1 more source

Neuroleptic malignant syndrome induced by concomitant use of risperidone and quetiapine

CHRISMED Journal of Health and Research, 2016
Neuroleptic malignant syndrome (NMS) is a rare but life-threatening condition induced by neuroleptic medications. In severe cases, NMS can rapidly lead to death. NMS is reported less frequently now-a-days with the advent of new antipsychotic drugs.
Mustafa Volkan Demir, Tuba Ozturk Demir, Selcuk Yaylaci, Huseyin Yildiz, Ibrahim Tayci, Mustafa Baydar   +5 more
doaj   +1 more source